Walgreens sees a long runway for its two-year-old clinical trials business as it doubles down on its core retail pharmacy operations. Ramita Tandon, chief clinical trials officer, shared insights about Walgreens’ strategy to ramp up its clinical research capabilities during TD Cowen’s recent 9th Annual FutureHealth ConferenceFutureHealth ConferenceFutureHealth Conference. The retail pharmacy giant says it has reached more than five million patients to potentially recruit into clinical trials since launching the business in June 2022. The company’s clinical trial unit now works with 25 unique customers across biopharma, academic institutions, non-profit and government partners and has signed more than 35 clinical trial contracts.
Read the full article: Walgreens Eyes ‘Tremendous Growth’ for Clinical Trials as Part of Transformation Strategy //
Source: https://www.fiercehealthcare.com/retail/walgreens-eyes-tremendous-growth-clinical-trials-part-transformation-strategy